Tandem Diabetes Care, Inc. (Nasdaq: TNDM) and Dexcom, Inc. today announced that following the recent authorization of sale by ...

The data is sent to smartphones and can be shared with physicians or data centers. For people with diabetes, continuous ...

The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

PPG sensors can determine things like heart rate, blood pressure, and sleep apnea. They are often built into smartwatches. The data is sent from the watch to the user’s smartphone. Then it can be ...

Continuous Glucose Monitoring Devices Market was valued at US$ 5.89 Bn in 2024 and is to reach a value of US$ 12.51 Bn by 2031 at a CAGR of 9.9%.

In the trailing four quarters, it delivered an earnings beat of nearly 8.3%, on average. More on TNDM’s Latest Integrated Offering G7 is Dexcom’s smallest sensor to date and is hailed as the most ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors ...

Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries.

PODD stock stays on investors' radar owing to its solid progress with Omnipod 5 and robust potential in the diabetes market.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

Insulet Corp., manufacturer of the tubeless Omnipod Insulin Management System, has been awarded $452 million in damages after it successfully defended its intellectual property against ...

Tandem Diabetes Care has received authorization of sale by Health Canada, paving the way for in-warranty t:slim X2 insulin pump users to be full compatibility with both the Dexcom G7 and Dexcom G6 ...